Literature DB >> 11799162

Effect of latent human immunodeficiency virus infection on cell surface phenotype.

David G Brooks1, Jerome A Zack.   

Abstract

Highly active antiretroviral therapy has succeeded in many cases in suppressing virus production in patients infected with human immunodeficiency virus (HIV); however, once treatment is discontinued, virus replication is rekindled. One reservoir capable of harboring HIV in a latent state and igniting renewed infection once therapy is terminated is a resting T cell. Due to the sparsity of T cells latently infected with HIV in vivo, it has been difficult to study viral and cellular interactions during latency. The SCID-hu (Thy/Liv) mouse model of HIV latency, however, provides high percentages of latently infected cells, allowing a detailed analysis of phenotype. Herein we show that latently infected cells appear phenotypically normal. Following cellular stimulation, the virus completes its life cycle and induces phenotypic changes, such as CD4 and major histocompatibility complex class I down-regulation, in the infected cell. In addition, HIV expression following activation did not correlate with expression of the cellular activation marker CD25. The apparently normal phenotype and lack of HIV expression in latently infected cells could prevent recognition by the immune response and contribute to the long-lived nature of this reservoir.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799162      PMCID: PMC135922          DOI: 10.1128/jvi.76.4.1673-1681.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Induction of HIV-1 replication by allogeneic stimulation.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.

Authors:  H Blaak; A B van't Wout; M Brouwer; B Hooibrink; E Hovenkamp; H Schuitemaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Re-emergence of HIV after stopping therapy.

Authors:  T W Chun; R T Davey; D Engel; H C Lane; A S Fauci
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

5.  Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.

Authors:  E S Withers-Ward; R G Amado; P S Koka; B D Jamieson; A H Kaplan; I S Chen; J A Zack
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

6.  The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

Authors:  B Ramratnam; J E Mittler; L Zhang; D Boden; A Hurley; F Fang; C A Macken; A S Perelson; M Markowitz; D D Ho
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

7.  Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms.

Authors:  G Kovalev; K Duus; L Wang; R Lee; M Bonyhadi; D Ho; J M McCune; H Kaneshima; L Su
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

8.  Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals.

Authors:  M A Ostrowski; T W Chun; S J Justement; I Motola; M A Spinelli; J Adelsberger; L A Ehler; S B Mizell; C W Hallahan; A S Fauci
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.

Authors:  H F Günthard; S D Frost; A J Leigh-Brown; C C Ignacio; K Kee; A S Perelson; C A Spina; D V Havlir; M Hezareh; D J Looney; D D Richman; J K Wong
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

10.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

View more
  20 in total

1.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Authors:  David G Brooks; Philip A Arlen; Lianying Gao; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

3.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 4.  Studies of retroviral infection in humanized mice.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Virology       Date:  2015-02-11       Impact factor: 3.616

5.  Establishment and maintenance of HIV latency: model systems and opportunities for intervention.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Future Virol       Date:  2010-01-01       Impact factor: 1.831

6.  Primary cell model for activation-inducible human immunodeficiency virus.

Authors:  Bryan Burke; Helen J Brown; Matthew D Marsden; Gregory Bristol; Dimitrios N Vatakis; Jerome A Zack
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Authors:  Carter R Coberley; James J Kohler; Joseph N Brown; Joseph T Oshier; Henry V Baker; Michael P Popp; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.

Authors:  Maria Iglesias-Ussel; Claire Vandergeeten; Luigi Marchionni; Nicolas Chomont; Fabio Romerio
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.

Authors:  Vyjayanthi Krishnan; Steven L Zeichner
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Regulation of HIV-1 latency by T-cell activation.

Authors:  Samuel A Williams; Warner C Greene
Journal:  Cytokine       Date:  2007-07-20       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.